Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methadone + acetaminophen is a combination of two analgesic agents used together for the management of pain. Methadone is a synthetic opioid analgesic that acts primarily as a full agonist at the µ-opioid receptor, with additional activity as an antagonist at the N-methyl-D-aspartate (NMDA) receptor and inhibitor of serotonin and norepinephrine reuptake. It is indicated for severe pain not responsive to alternative treatments and for opioid dependence therapy[3][6][10]. Acetaminophen (paracetamol) is a non-opioid analgesic and antipyretic agent, commonly used to treat mild to moderate pain and fever by inhibiting prostaglandin synthesis in the central nervous system[5]. The combination may be considered when both opioid-level pain control and non-opioid adjunctive therapy are needed. There are no highly clinically significant interactions reported between methadone and acetaminophen, but clinical monitoring remains prudent[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methadone + acetaminophen.